Two-Year Clinical Outcome of the TWENTE Trial, a Randomized Controlled Trial Comparing Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

被引：0
|
作者：
von Birgelen, Clemens [1 ]
Tandjung, Kenneth [1 ]
Sen, Hanim [1 ]
Basalus, Mounir [1 ]
Louwerenburg, J. Hans [1 ]
Stoel, Martin [1 ]
van Houwelingen, K. Gert [1 ]
Linssen, Gerard [2 ]
Said, Salah [3 ]
Nienhuis, Mark [4 ]
Lowik, Marije [1 ]
van der Palen, Job [5 ]
Verhorst, Patrick [1 ]
de Man, Frits [1 ]
机构：
[1] Thoraxctr Twente, Enschede, Netherlands
[2] Ziekenhuisgrp Twente, Almelo, Netherlands
[3] Ziekenhuisgrp Twente, Hengelo, Netherlands
[4] Streekziekenhuis Koningin Beatrix, Winterswijk, Netherlands
[5] Univ Twente, NL-7500 AE Enschede, Netherlands
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 60卷 / 17期
关键词：
D O I：
10.1016/j.jacc.2012.08.056
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：B15 / B15
页数：1
相关论文
共 50 条
  • [41] Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT)
    Natsuaki, Masahiro
    Kozuma, Ken
    Morimoto, Takeshi
    Kadota, Kazushige
    Muramatsu, Toshiya
    Nakagawa, Yoshihisa
    Akasaka, Takashi
    Hanaoka, Keiichi Igarashi
    Tanabe, Kengo
    Morino, Yoshihiro
    Nishikawa, Hideo
    Kimura, Takeshi
    [J]. EUROINTERVENTION, 2018, 14 (07) : 815 - 818
  • [42] THREE-YEAR OUTCOME OF ALL-COMER PATIENTS TREATED WITH RESOLUTE ONYX ZOTAROLIMUS-ELUTING VERSUS ORSIRO SIROLIMUS-ELUTING STENTS IN THE RANDOMIZED BIONYX TRIAL
    Ploumen, Eline
    Zocca, Paolo
    Buiten, Rosaly A.
    Doggen, C.
    Aminian, Adel
    Schotborgh, Carl
    Jessurun, Gillian A. J.
    Roguin, Ariel
    Danse, Peter W.
    Benit, Edouard
    von Birgelen, Clemens
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1026 - 1026
  • [43] Comparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patients
    Miyazaki, Tadashi
    Latib, Azeem
    Panoulas, Vasileios F.
    Miyazaki, Sakiko
    Costopoulos, Charis
    Sato, Katsumasa
    Naganuma, Toru
    Kawamoto, Hiroyoshi
    Daida, Hiroyuki
    Colombo, Antonio
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 86 (01) : E11 - E18
  • [44] EVEROLIMUS-ELUTING XIENCE PRIME/X PEDITION VERSUS ZOTAROLIMUS-ELUTING RESOLUTE INTEGRITY STENTS IN PATIENTS WITH DIABETES MELLITUS AND SMALL VESSEL DISEASE: AN ANALYSIS FROM THE 2-YEAR PROSPECTIVE RANDOMIZED COPERES STUDY
    Yun, Wonsik
    Kim, Yisik
    Lee, Sang-Rok
    Chae, Jei-Keon
    Lee, Ja-Yeon
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1501 - 1501
  • [45] TWO-YEAR CLINICAL OUTCOMES OF EVEROLIMUS-ELUTING STENTS VERSUS PACLITAXEL-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: INSIGHTS FROM RANDOMIZED TRIALS
    Zhang, Feng
    Qian, Juying
    Ge, Junbo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1820 - E1820
  • [46] Two-year clinical outcome in a randomized trial comparing sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization: the SIRTAX trial
    Wenaweser, P.
    Beutler, J.
    Taghetchian, K.
    Eberli, F.
    Maier, W.
    Meier, B.
    Juni, P.
    Windecker, S.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 768 - 768
  • [47] 1-year angiographic and 5-year clinical outcome of cobalt-chromium everolimus-eluting versus zotarolimus-eluting coronary stents in patients with multivessel CAD
    Pershukov, I.
    Omarov, A.
    Batyraliev, T.
    Ramazanov, J.
    Karben, Z.
    Sidorenko, B.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [48] Percutaneous Coronary Intervention With Second-Generation Paclitaxel-Eluting Stents Versus Everolimus-Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial)
    Waksman, Ron
    Ghali, Magdi
    Goodroe, Randy
    Ryan, Thomas
    Turco, Mark
    Ring, Michael
    McGarry, Thomas
    Dobies, David
    Shammas, Nicolas
    Steinberg, Daniel H.
    Swymelar, Stacy
    Kaneshige, Kimberly
    Torguson, Rebecca
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (08): : 1119 - 1124
  • [49] A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents The RIBS IV Randomized Clinical Trial
    Alfonso, Fernando
    Perez-Vizcayno, Maria Jose
    Cardenas, Alberto
    del Blanco, Bruno Garcia
    Garcia-Touchard, Arturo
    Lopez-Minguez, Jose Ramon
    Benedicto, Amparo
    Masotti, Monica
    Zueco, Javier
    Iniguez, Andres
    Velazquez, Maite
    Moreno, Raul
    Mainar, Vicente
    Dominguez, Antonio
    Pomar, Francisco
    Melgares, Rafael
    Rivero, Fernando
    Jimenez-Quevedo, Pilar
    Gonzalo, Nieves
    Fernandez, Cristina
    Macaya, Carlos
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (01) : 23 - 33
  • [50] A Randomized Controlled Trial Comparing BioMime Sirolimus-Eluting Stent With Everolimus-Eluting Stent: Two-Year Outcomes of the meriT-V Trial
    Abizaid, Alexandre
    Costa, Ricardo
    Kedev, Sasko
    Kedhi, Elvin
    Talwar, Suneel
    Erglis, Andrejs
    Hlinomaz, Ota
    Masotti, Monica
    Fath-Ordoubadi, Farzin
    Milewski, Krzysztof
    Lemos, Pedro
    Botelho, Roberto
    Ijsselmuiden, Alexander
    Koolen, Jacques
    Kala, Petr
    Janssens, Luc
    Chandra, Udita
    [J]. CARDIOLOGY RESEARCH, 2023, 14 (04) : 291 - 301
12345